Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

Network meta-analysis and cost per responder of targeted Immunomodulators in the treatment of active psoriatic arthritis

Abstract Background Multiple targeted immunomodulators (TIMs) for psoriatic arthritis (PsA) treatment are available, but limited studies have directly compared these agents. This study indirectly compared the efficacy of TNF-α, interleukins, and phosphodiesterase-4 inhibitors for treatment of active...

Full description

Bibliographic Details
Main Authors: Vibeke Strand, M. Elaine Husni, Keith A. Betts, Yan Song, Rakesh Singh, Jenny Griffith, Marci Beppu, Jing Zhao, Arijit Ganguli
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Rheumatology
Subjects:
Arthritis, psoriatic
Meta-analysis
Immunomodulators
Cost-benefit analysis
Online Access:http://link.springer.com/article/10.1186/s41927-018-0011-1

Internet

http://link.springer.com/article/10.1186/s41927-018-0011-1

Similar Items